Medunik USA Inc.
$2.1K 52 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Thermo Fisher Scientific Asheville LLC
Thermo Fisher Scientific Asheville LLC reported $2,190.64 across General Payments, Research, and Ownership to 13 physicians and teaching hospitals across 13 transactions.
- $2.2K Below-median payer
- All-tracks total
- 13 Below-median volume
- Transactions
- 13 Below-median reach
- Recipients
- −$2.1K
- General Payments vs PY2023
Thermo Fisher Scientific Asheville LLC reported $2,190.64 across all CMS Open Payments tracks (General + Research + Ownership) to 13 physicians and teaching hospitals in Program Year 2024 - ranking #1789 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,190.64, averaging $168.51 per recipient.
Thermo Fisher Scientific Asheville LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer thermo-fisher-scientific-asheville-llc Thermo Fisher Scientific Asheville LLC
$2.2K · #1789/1,925 · 0.0% industry · PY2024
- TOT $2.2K
- RANK #1789
- SHARE 0.0%
- TXN 13
- RCP 13
- CAT 1
- GEN $2.2K
- ΔGEN −$2.1K
- TOP1 33.2%
- PY 2024
Volume peers
Nearest volume peer: Medunik USA Inc. ($2.1K)
Thermo Fisher Scientific Asheville LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Thermo Fisher Scientific Asheville LLC's CMS-reported General Payments decreased by $2.1K (−49.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: THERMO FISHER SCIENTIFIC ASHEVILLE LLCPY2024: Thermo Fisher Scientific Asheville LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $4,298.70
- PY2024
- $2,190.64
What the Data Shows for Thermo Fisher Scientific Asheville LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Thermo Fisher Scientific Asheville LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Debt Forgiveness" at $2.2K, accounting for 100.0% of this company's General Payments and 13 transactions.
General Payment Breakdown by Type
Across 1 types of general payments, Thermo Fisher Scientific Asheville LLC's largest category was "Debt Forgiveness" at $2.2K - 100.0% of General Payments.
How Thermo Fisher Scientific Asheville LLC divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Debt Forgiveness | $2.2K | 13 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,636.03 (74.7%) of $2,190.64 in this company's General Payments records across 11 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Thermo Fisher Scientific Asheville LLC
The five named recipients with the highest reported General Payments from this company
- 1
Valley Medical Center
$726.66 across 1 reported transactions
- 2
St. Josephs Hospital & Medical Ctr
$388.80 across 1 reported transactions
- 3
Spectrum Health Hospitals
$215.28 across 2 reported transactions
- 4
University Of Vermont Medical Center
$164.00 across 1 reported transactions
- 5
Anne Arundel Medical Center Inc.
$141.29 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Thermo Fisher Scientific Asheville LLC ranks #1789 of 1,925 by total payments (bottom 7% by spend) but is notably more concentrated than that alone would suggest -- #806 of 1,838 by HHI (top 44% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- bluebird bio, Inc. : $208.3K total payments, HHI 1750
- Pfizer International LLC : $197.5K total payments, HHI 1747
- NextStep Arthropedix, LLC : $125.7K total payments, HHI 1747
- Greiner Bio-One North America, Inc. : $11.6K total payments, HHI 1746
- CashFlow Solutions, LLC : $89.2K total payments, HHI 1745
- Acumed LLC : $3.4M total payments, HHI 1742
- Thermo Fisher Scientific Asheville LLC (this company) : $2.2K total payments, HHI 1739
- Albireo Pharma, Inc. : $317.2K total payments, HHI 1739
- Puma Biotechnology, Inc. : $396.8K total payments, HHI 1733
- Pulse Biosciences, Inc. : $534.8K total payments, HHI 1730
- SS White Burs, Inc. : $65.6K total payments, HHI 1718
- Maquet Cardiovascular L.L.C. : $188.3K total payments, HHI 1714
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Thermo Fisher Scientific Asheville LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Thermo Fisher Scientific Asheville LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Thermo Fisher Scientific Asheville LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Dymicron
$2.3K 1 recipients
Compare payment profiles
Vision Quest Industries Inc.
$2.1K 72 recipients
Compare payment profiles
American National Red Cross
$2.1K 11 recipients
Compare payment profiles
Elekta Medical, S.A.
$2.3K 1 recipients
Compare payment profiles
Oxford Gene Technology Inc
$2.3K 87 recipients
Compare payment profiles
Put this to use
Thermo Fisher Scientific Asheville LLC ranks #1789 of 1,925 by all-tracks total payments, led by "Debt Forgiveness".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Debt Forgiveness" spend across every manufacturer, not just Thermo Fisher Scientific Asheville LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.